The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Inflammatory Disease Treatment With Complement Inhibitors - EP3980047

The patent EP3980047 was granted to RA Pharmaceuticals on Feb 14, 2024. The application was originally filed on Jun 4, 2020 under application number EP20749996A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3980047

RA PHARMACEUTICALS
Application Number
EP20749996A
Filing Date
Jun 4, 2020
Status
Granted And Under Opposition
Jan 12, 2024
Publication Date
Feb 14, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

KRAUSSNov 11, 2024KRAUSSADMISSIBLE

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS10106579
DESCRIPTIONUS2011172126
DESCRIPTIONUS2017137468
DESCRIPTIONUS9937222
DESCRIPTIONWO2017105939
DESCRIPTIONWO2018106859
OPPOSITIONUS2017137468
OPPOSITIONWO2012088247

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents